Progressive Care Inc (fka RXMD)

[OhManIDied]

There--are many--reasons to--expect stellar--revenues this--January.

1) This year's seasonal flu reached epidemic levels at the very end of December.
-- In addition to running a brick-and-mortar store, RXMD specializes in health risk management and provides medicine to long-term (senior) care facilities. Seniors happen to be one of the primary recipients of flu medicines.
http://www.newsweek.com/flu-has-reached-epidemic-levels-cdc-says-296122

2) The PharmCo pharmacy has recently been renovated. They also increased and improved their sales staff and methods.
http://finance.yahoo.com/news/progressive-care-releases-open-letter-140000795.html
http://finance.yahoo.com/news/progressive-care-inc-pharmco-fills-140000895.html
-- This all happened before started reporting again. We inherited it in great shape to begin with.
-- The reward for their efforts was quickly recognized, providing record sales in December and proving it to be both effective and cost-efficient. There is no reason to think that the growth trend will suddenly stop shortly after the adoption of new policies, in fact, as they work out the kinks and bottle-necks in their new operating procedures, they should continue to improve, potentially at an even faster rate.

3) The partnership with Caremed is bound to increase revenue and reduce the cost of operations.
http://finance.yahoo.com/news/progressive-care-announces-co-joint-180000223.html
-- Caremed has a similar business model as PharmCo and, through their mutually-beneficial partnership, both companies can take advantage of economies of scale while saving on expenses/services that will overlap. This development alone may be enough to send the company net profitable during Q1. Combined with the fact that (at this rate) all the liabilities are going to be settled with a max OS around 100M, there will be no further need to dilute in a way that will hurt shareholder value (more on this later)
-- It is of note that Caremed is the larger company, with a higher average prescriptions per month during 2014. RXMD may stands to gain slightly more from the exchange of equity in each business, which was equal.

3) RXMD's parnership with "Health Care of South Florida" will boost the growth of the highly-lucrative health care management and long-term care facility business where, by the way, the market for such services is enormous.
http://finance.yahoo.com/news/progressive-care-announces-alliance-health-143000526.html
-- Improved efficacy and safety resulting from this partnership will significantly add value to RXMD's service for any property/business manager.
-- This alliance created a new, direct link between RXMD and the target consumers - which Health Care of South Florida already works with - instantly increasing market share.

4) RXMD's plan to move into non-sterile compound pharmaceuticals, an extremely high-margin niche of the pharmaceutical industry.
-- One of the key barriers to growth in this niche is the need for consistent cash flow, especially if the business volume is ballooning. The recent elimination of liabilities (via the agreement with Tarpon) will make it much easier for the company to obtain a revolving line of credit to use toward their cash flow needs, allowing the business to explode in a relatively short period of time.
-- The above point means no further share issuance unless it is a great acquisition or business play that will only benefit the shareholders.

There is so much going on here with RXMD. It is extremely undervalued using very conservative metrics to estimate the price target of 0.11 without accounting for the majority of what is written above or any level of profitability/growth which will more than likely be seen at some point, perhaps early this year.

See conservative price target and comparison in this stickied post:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110162555

Here is an excellent article which supplements all of the above information well:
http://www.microcapdaily.com/progressive-care-inc-otcmktsrxmd-making-moves/18524/

RXMD